PCMH
BLTE

Polymer Capital Management (HK)’s Belite Bio BLTE Stock Holding History

Polymer Capital Management (HK)’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-7,266
Closed -$538K – 145
2025
Q3 		$538K Buy
+7,266
New +$477K 0.07% 132

Other funds holding BLTE

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Polymer Capital Management (HK)'s BLTE Position: Q4 2025 in Review

Polymer Capital Management (HK) sold out of Belite Bio (BLTE) in Q4 2025, closing a stake of 7,266 shares — an estimated $538K sold.

Polymer Capital Management (HK) first reported a position in BLTE in Q3 2025 and held it in 1 quarter. The position peaked at $538K in Q3 2025. 69 funds tracked by Wall St. Rank hold BLTE as of Q4 2025.

  • Polymer Capital Management (HK) reported no remaining Belite Bio position as of Q4 2025 after selling out during the quarter.
  • Polymer Capital Management (HK) sold 7,266 Belite Bio shares in Q4 2025, an estimated $538K.
  • Polymer Capital Management (HK) first reported a position in Belite Bio in Q3 2025 and held it in 1 quarter.
  • Polymer Capital Management (HK)'s Belite Bio position peaked at $538K in Q3 2025.
  • 69 funds tracked by Wall St. Rank held Belite Bio as of Q4 2025.

Based on Polymer Capital Management (HK)'s 13F filing for Q4 2025, filed 13 Feb 2026.